Clinical Trial Update: Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating radiation therapy combined with thalidomide and temozolomide for patients with newly diagnosed brain metastases is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Brain and Central Nervous System Tumors

Drugs mentioned

• Temozolomide (Temozolomide)
• Thalidomide (thalidomide)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Brain and Central Nervous System Tumors, Unspecified Adult Solid Tumor, Protocol Specific | Phase 2 | Status: COMPLETED